Showing results (1921-1930 of 3,888) with videos related to

Sort By:
Pageof 389
Cancer Biology & Therapy|June 27, 2024
Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinomaNicole M Naranjo, Anne Kennedy, Anna Testa, et al.
Cancer Biology & Therapy|July 23, 2024
Association between the IL1B-511 C>T polymorphism and the risk of hematologic malignancies: data from a meta-analysisFabíola Silva Alves-Hanna, Felipe Rodolfo Pereira Silva, Daniele Sá Pereira, et al.
Cancer Biology & Therapy|May 13, 2024
METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancerLijie Li, Jie Zeng, Sili He, et al.
Cancer Biology & Therapy|December 18, 2025
Validation of the important role and prognostic value of KIF14 in triple-negative breast cancerJingjing Yuan, Meilin Zhang, Yaxuan Liu, et al.
Cancer Biology & Therapy|November 30, 2025
High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcomaMolly R Danks, Piotr J Manasterski, Henry Beetham, et al.
Cancer Biology & Therapy|December 24, 2025
Assessing progesterone receptor modulation in glioblastoma: from in vitro and animal model to a human pilot protocolDenisse Arcos-Montoya, Patricia García-López, Talia Wegman-Ostrosky, et al.
Cancer Biology & Therapy|December 3, 2025
Toll-like receptor 4 inhibition sensitizes non-small cell lung cancer to radiotherapyRyma Haroun, Cleopatra Rutihinda, Aissatou Hadja Diallo, et al.
Cancer Biology & Therapy|April 23, 2024
Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case reportLisha Li, Dandan Yu, Jinru Yang, et al.
Cancer Biology & Therapy|January 11, 2024
Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor modelsBrajesh P Kaistha, Gozde Kar, Andreas Dannhorn, et al.
Cancer Biology & Therapy|January 5, 2024
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARαZhenyuan Qian, Wenfa Lin, Xufan Cai, et al.
Pageof 389